Skip to main content
Equibles

Armen Shanafelt

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Armen Shanafelt

Earlier roles on record: Board Member at Spyre Therapeutics, Inc. (SYRE) until June 22, 2023. Spyre Therapeutics, Inc. reported in an 8-K filed June 23, 2023 that Armen Shanafelt resigned as Board and any respective committee of the Board, effective June 22, 2023.

“on June 22, 2023, immediately prior to the effective time of the merger (“Effective Time”), Armen Shanafelt, Ph.D., V. Bryan Lawlis, Ph.D. and Marcio Souza, M.B.A. resigned from the Board and any respective committee of the Board to which they were members.”
Spyre Therapeutics, Inc. Form 8-K, filed June 23, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.